Blood Group Typing Market Research by Product, Test Type, Technique, End User and Top Companies - Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.)

Blood Group Typing Market research report provides an analytical measurement of the main challenges faced by the business currently and in the upcoming years. This market report also offers a profound overview of product specification, technology, product type and production analysis by taking into account most important factors such as revenue, cost, and gross margin. Proficient capabilities and excellent resources in research, data collection, development, consulting, evaluation, compliance and regulatory services come together to generate this world-class market research report. This Blood Group Typing Market report is especially designed by keeping in mind the customer requirements which will ultimately assist them in boosting their return on investment (ROI).

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=980022

The major players in the market are:

Bio-Rad Laboratories, Inc. (U.S.),
Grifols, S.A. (Spain),
Immucor, Inc. (U.S.),
Ortho Clinical Diagnostics, Inc. (U.S.),
Quotient, Ltd. (U.S.), ),
Novacyt Group (France),
BAG Healthcare GmbH (Germany),
Rapid Labs (U.K.),
Day medical SA (Switzerland),
DIAGAST (France),
and AXO Science (France).

Based on product and service, the market is segmented into consumables, instruments, and services. The consumables segment is further categorized into anti sera reagents, anti-human globulin reagents, red blood cells reagents, and blood bank saline. The consumables segment is expected to grow at the highest CAGR during the forecast period. The increase in blood donation rates and major surgical procedures (including organ transplant procedures) are the key factors driving the growth of this segment.

Based on test type, the market is segmented into antibody screening, HLA typing, cross-matching tests, ABO blood tests, and antigen typing. The antibody screening segment is expected to grow at the highest CAGR during the forecast period. The growth of this market segment is primarily driven by the increasing prevalence of chronic disorders and growing demand for the early diagnosis of diseases.

Geographically, North America accounted for the largest share of the market in 2016. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for several surgeries, and increasing incidence of major disorders. In addition, the high growth potential in the Asian region provides opportunities for players in the market.

Research Coverage

The blood group typing market is segmented based on product and service, technique, test type, end user, and region. Apart from comprehensive geographic & devices analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the blood group typing market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the blood group typing market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the blood group typing market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for blood group typing products across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood group typing market.

The blood group typing market is projected to reach USD 3.12 billion by 2021 from USD 1.95 billion in 2016, at a CAGR of 9.8%. Growth in the blood group typing market is primarily attributed to the increasing demand for blood and blood products, a growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences. Stringent regulatory standards for blood transfusion are also expected to fuel the growth of the blood group typing market during the forecast period.

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=980022

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Blood Group Typing: Market Overview
4.2 Geographic Analysis: Blood Group Typing Market, By End User (2016)
4.3 Geographical Snapshot of the Blood Group Typing Market
4.4 Blood Group Typing Market Size, By Technique, 2016 vs 2021

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Blood Donations
5.2.1.2 Growing Number of Road Accidents, Emergencies, and Trauma Cases Necessitating Blood Transfusions
5.2.1.3 Increasing Demand for Blood Group Typing in Prenatal Testing
5.2.1.4 Increasing Usage of Blood Group Typing in Forensic Sciences
5.2.1.5 Stringent Regulatory Standards for Blood Transfusion Will Fuel Market Growth
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.2.2 Blood Group Typing With Molecular Diagnostics

6 Blood Group Typing Market, By Product and Service
6.1 Introduction
6.2 Consumables
6.2.1 Antisera Reagents
6.2.2 Red Blood Cell Reagents
6.2.3 Anti-Human Globulin Reagents
6.2.4 Blood Bank Saline
6.3 Instruments
6.4 Services

7 Blood Group Typing Market, By Technique
7.1 Introduction
7.2 PCR-Based and Microarray Techniques
7.3 Assay-Based Techniques
7.4 Massively Parallel Sequencing
7.5 Other Techniques

8 Blood Group Typing Market, By Test Type
8.1 Introduction
8.2 Antibody Screening
8.3 HLA Typing
8.4 ABO Blood Tests
8.5 Cross-Matching Tests
8.6 Antigen Typing

9 Blood Group Typing Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Blood Banks
9.5 Other End Users

10 Blood Group Typing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 RoE
10.4 Asia
10.5 Rest of the World

11 Competitive Landscape
11.1 Introduction
11.2 Vendor Dive Overview
11.2.1 Vanguards
11.2.2 Innovator
11.2.3 Dynamic
11.2.4 Emerging
11.3 Competitive Benchmarking
11.3.1 Product Offerings (For All 25 Players)
11.3.2 Business Strategy (For All 25 Players)

12 Company Profiles
12.1 Bio-Rad Laboratories, Inc.
12.1.1 Overview
12.1.2 Products Offered
12.1.3 Company Scorecard
12.1.3.1 Product Offerings
12.1.3.2 Business Strategy
12.1.4 Recent Developments (2014-2017)
12.2 Beckman Coulter (A Subsidiary of Danaher)
12.2.1 Overview
12.2.2 Products Offered
12.2.3 Company Scorecard
12.2.3.1 Product Offerings
12.2.3.2 Business Strategy
12.2.4 Recent Developments (2014-2017)
12.3 Grifols International, S.A.
12.3.1 Overview
12.3.2 Products Offered
12.3.3 Company Scorecard
12.3.3.1 Product Offerings
12.3.3.2 Business Strategy
12.3.4 Recent Developments (2014-2017)
12.4 Immucor, Inc.
12.4.1 Overview
12.4.2 Products Offered
12.4.3 Company Scorecard
12.4.3.1 Product Offerings
12.4.3.2 Business Strategy
12.4.4 Recent Developments (2014-2017)
12.5 Merck KGaA
12.5.1 Overview
12.5.2 Products Offered
12.5.3 Company Scorecard
12.5.3.1 Product Offerings
12.5.3.2 Business Strategy
12.5.4 Recent Developments (2014–2017)
12.6 Novacyt Group
12.6.1 Overview
12.6.2 Products Offered
12.6.3 Company Scorecard
12.6.3.1 Product Offerings
12.6.3.2 Business Strategy
12.6.4 Recent Developments (2014–2017)
12.7 Quotient, Ltd.
12.7.1 Overview
12.7.2 Products Offered
12.7.3 Company Scorecard
12.7.3.1 Product Offerings
12.7.3.2 Business Strategy
12.7.4 Recent Developments (2014-2017)
12.8 Ortho Clinical Diagnostics, Inc.
12.8.1 Overview
12.8.2 Products Offered
12.8.3 Company Scorecard
12.8.3.1 Product Offerings
12.8.3.2 Business Strategy
12.8.4 Recent Developments (2014-2017)
12.9 Bag Health Care GmbH
12.9.1 Overview
12.9.2 Products Offered
12.9.3 Company Scorecard
12.9.3.1 Product Offerings
12.9.3.2 Business Strategy
12.9.4 Recent Developments (2014-2017)
12.10 Rapid Labs
12.10.1 Overview
12.10.2 Products Offered
12.10.3 Company Scorecard
12.10.3.1 Product Offerings
12.10.3.2 Business Strategy
12.10.4 Recent Developments (2014-2017)
12.11 AXO Science
12.11.1 Overview
12.11.2 Products Offered
12.11.3 Company Scorecard
12.11.3.1 Product Offerings
12.11.3.2 Business Strategy
12.11.4 Recent Developments (2014-2017)
12.12 Agena Bioscience, Inc.
12.12.1 Overview
12.12.2 Products Offered
12.12.3 Company Scorecard
12.12.3.1 Product Offerings
12.12.3.2 Business Strategy
12.12.4 Recent Developments (2014-2017)
12.13 Day Medical SA
12.13.1 Overview
12.13.2 Products Offered
12.13.3 Company Scorecard
12.13.3.1 Product Offerings
12.13.3.2 Business Strategy
12.13.4 Recent Developments (2014-2017)

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

Get Direct Order of this Report @ https://www.reportsnreports.com/purchase.aspx?name=980022

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.